PetMed Express, Inc. Q1 2027 Earnings Call Summary
PetMed Express, Inc. shared its Q1 2027 earnings during an investor call. The company is shifting away from traditional advertising and focusing on new B2B and white-label pharmacy options. Revenue has stabilized over the past three quarters, despite year-over-year declines in the prescription medication sector. Strategic upgrades, such as a new SAP ERP system and call center platform, have improved operational efficiency.
Customer acquisition costs dropped 15% after eliminating costly media programs. Delivery times for West Coast customers were reduced by up to two days through logistics improvements. Recurring sales from auto-ship and memberships now account for 61.5% of total sales. The company is also streamlining costs, cutting G&A expenses by 14% and advertising spend by 30%.
An upcoming sale-leaseback of the Delray Beach headquarters could unlock real estate value. The board is seeking a permanent CEO to drive long-term value. A cash acquisition offer from Silver Cape Investments was received but no decision has been made. Despite lower manufacturer rebates, net loss narrowed to $6.1 million after eliminating a $34.2 million goodwill impairment charge.
The company plans to establish a 10-year lease after selling the headquarters to improve financial flexibility.
Written by urgent.news from Yahoo Finance's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
